DaVita Inc

Research DaVita Inc (DVA) on Bullrun: valuation model: 1.6% undervalued, market cap USD 14.10B, P/E 21.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDVA
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyUSD
• Valuation signal1.6% undervalued
• Market capUSD 14.10B
• P/E21.1
• Financial periodFY2025
• RevenueUSD 13.64B
• Revenue growth6.5%
• Net incomeUSD 1.08B
• Free cash flowUSD 1.31B

Valuation Snapshot

Bullrun's latest valuation model marks DaVita Inc as 1.6% undervalued; latest market cap is USD 14.10B; P/E is 21.1.

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients;

Frequently asked questions

Is DaVita Inc overvalued or undervalued?

Bullrun's valuation model currently marks DaVita Inc as 1.6% undervalued.

What is DaVita Inc's market cap?

DaVita Inc's market capitalization is USD 14.10B.

What is DaVita Inc's P/E ratio?

DaVita Inc's price-to-earnings (P/E) ratio is 21.1.

What does DaVita Inc do?

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.